ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• eConsent For Complex Clinical Trials

  Master protocol design trials require an endless stream of consent forms, adding time, cost, and risk. Learn how a feature-rich eConsent platform can simplify those processes and improve engagement.

• Study Start-Up Checklist For Digital Clinical Trials

  Read how five Florence employees with clinical research backgrounds came together to craft a checklist designed to walk sites through the process of tech-enabled study start-up.  

• Enhancing Participant Payments: A New Approach

  Managing participant payments in clinical trials is a multifaceted challenge impacting participants, sites, and sponsors alike. Delve into the intricacies and numerous hurdles faced in this process.

• Avoiding Vaporware – Even More Questions To Ask eClinical Platform Providers

  For a platform that aligns with the demands of modern clinical research, delve into these considerations to ensure your choice supports your study’s success.

• The False Economy Of Paper Diaries In Clinical Trials

  While paper diaries may appear cheaper, but there are hidden costs that make a digital eCOA solution much more affordable in your clinical trial.

• The Right EDC Solution For Oncology Trials

  Oncology clinical trials can be very complex, as are their data management needs. Understand why selecting the right EDC is crucial for managing them efficiently while providing compassionate care.

• Standardize Vaccine Study Launch Timelines To Just 5 Weeks

  Uncover the pre-built vaccine trial solution that delivers quality and predictability for your entire immunology portfolio.

• Reducing Supply Risk in Cell & Gene Therapy Trials

  In cell and gene therapy trials, success depends on coordination. Learn how visibility, workflow control, and alignment help reduce risk and protect patient-specific treatments.

• What 9 Years Of MDR Experience Is Changing About PMCF Planning

  Re-evaluate your compliance roadmap by exploring expert perspectives on navigating regulatory shifts, distinguishing core surveillance obligations, and building a defensible, value-driven clinical data strategy.

• Top 5 Dos And Don'ts Of RTSM

  Discover best practices and common pitfalls for sponsors and vendors in RTSM as well as how to optimize your study by leveraging vendor expertise, avoiding delays, and embracing innovation.